Thyroid Hormone Activation in Human Vascular Smooth Muscle Cells: Expression of Type II Iodothyronine Deiodinase
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Abstract—Thyroid hormone has been reported to have significant effects on the peripheral vascular system, including relaxation of vascular smooth muscle cells and antiatherosclerotic effects. To exert its biological activity, thyroxine, which is a major secretory product of thyroid gland, needs to be converted to 3,5,3′-triiodothyronine (T 3) by iodothyronine deiodinase. Type I iodothyronine deiodinase (DI) is widely distributed and maintains circulating T 3 level, whereas type II iodothyronine deiodinase (DII) is present in a limited number of tissues to provide local intracellular T 3. In the present study, we have identified iodothyronine deiodinase in cultured human coronary artery smooth muscle cells (hCASMCs) and human aortic smooth muscle cells (hASMCs). All of the characteristics of the deiodinating activity in hCASMCs and hASMCs were compatible with DII. Northern analysis demonstrated that DII mRNA was expressed in both hCASMCs and hASMCs, and DII mRNA levels as well as DII activities were rapidly increased by dibutyryl-cAMP or forskolin. These data demonstrate, for the first time, the expression of DII in human vascular smooth muscle cells, which is regulated by a cAMP-mediated mechanism. The present results suggest a previously unrecognized role of local T 3 production by DII in the pathophysiology of human vascular smooth muscle cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular biological and biochemical characterization of the human type 2 selenodeiodinase.
Salvatore, D., Bartha, T., Harney, J. W., & Larsen, P. R. (1996) · Endocrinology · doi:10.1210/endo.137.8.8754756 · Cited by 284
Type 2 iodothyronine deiodinase is highly expressed in human thyroid.
Salvatore, D., Tu, H., Harney, J. W., & Larsen, P. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118880 · Cited by 196
Bartha, T., Kim, S.-W., Salvatore, D., Gereben, B., Tu, H. M., Harney, J. W., Rudas, P., & Larsen, P. R. (2000) · Endocrinology · doi:10.1210/endo.141.1.7282 · Cited by 118
Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes
Steinsapir, J., Harney, J., & Larsen, P. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4672 · Cited by 102
Kim, S.-W., Harney, J. W., & Larsen, P. R. (1998) · Endocrinology · doi:10.1210/endo.139.12.6334 · Cited by 86
Hosoi, Y. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3293 · Cited by 80
Research works printed but not linked: 26
- 10.1056/NEJM199512073332302 · DOI · Paper page
- 10.1089/thy.1996.6.505 · DOI · Paper page
- 10.1016/0002-9343(92)90782-7 · DOI · Paper page
- Perk M, O’Neill BJ. The effect of thyroid hormone therapy on angiographic coronary artery disease progression. Can J Cardiol. 1997;13:273–276.
- Leonard JL Koehrle J. Intracellular pathways of iodothyronine metabolism. In: Braverman LE Utiger RD eds. Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text. Philadelphia: Lippincott-Raven; 1996:125–161.
- Larsen PR. Thyroid hormone transport cellular uptake metabolism and molecular action. In: DeGroot LJ Larsen PR Hennermann G eds. The Thyroid and its Disease. New York: Churchill Livingstone Inc; 1996:61–111.
- 10.1074/jbc.270.45.26786 · DOI · Paper page
- 10.1172/JCI118806 · DOI · Paper page
- Ishikawa T, Chijiwa T, Hagiwara M, Mamiya S, Hidaka H. Thyroid hormones directly interact with vascular smooth muscle strips. Mol Pharmacol. 1989;35:760–765. · DOI
- 10.1111/j.1472-8206.1997.tb00167.x · DOI
- 10.1213/00000539-199710000-00005 · doi:10.1213/00000539-199710000-00005 · Paper page
- 10.1210/endo-107-5-1376 · DOI · Paper page
- 10.1210/endo-123-3-1676 · DOI
- 10.1016/0003-2697(76)90527-3 · DOI · Paper page
- 10.1172/JCI119032 · DOI
- Gittoes JLN, McCabe JC, Verhaeg J, Sheppard CM, Franklyn AJ. Thyroid hormone and estrogen receptor expression in normal pituitary and nonfunctional tumors of the anterior pituitary. J Clin Endocrinol Metab. 1997;82:1960–1967.
- 10.1210/endo-114-3-998 · DOI · Paper page
- 10.1210/endo.138.12.5602 · doi:10.1210/endo.138.12.5602 · Paper page
- 10.1074/jbc.272.29.18104 · DOI · Paper page
- 10.1210/endo.140.3.6594 · DOI · Paper page
- 10.1016/0014-2999(94)90407-3 · doi:10.1016/0014-2999(94)90407-3
- Walter U Waldmann R Nieberding M. Intracellular mechanism of action of vasodilators. Eur Heart J. 1988;9(suppl H):1–6. · doi:10.1093/eurheartj/9.suppl_h.1
- 10.1016/0021-9150(92)90035-F · DOI · Paper page
- 10.1530/eje.0.1360251 · DOI · Paper page
- 10.1152/physrev.1995.75.3.487 · DOI · Paper page
- 10.1161/res.82.12.1238 · doi:10.1161/res.82.12.1238
Cited by
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Hypothyroidism and Atherosclerosis
Cappola, A. R., & Ladenson, P. W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030398 · Cited by 640
Hypothyroidism as a Risk Factor for Cardiovascular Disease
Biondi, B., & Klein, I. (2004) · Endocrine · doi:10.1385/endo:24:1:001 · Cited by 412
Monzani, F., Caraccio, N., Kozàkowà, M., Dardano, A., Vittone, F., Virdis, A., Taddei, S., Palombo, C., & Ferrannini, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031669 · Cited by 399
Paradigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293
Metadata
- Authors
- Mizuma, H., Murakami, M., & Mori, M.
- Venue
- Circulation Research
- Published
- 2001-02-16
- Volume
- 88
- Issue
- 3
- Pages
- 313-318
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2155575761
- Cited by
- 121
- References
- 6
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.